ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    nct02329327
Previous Study | Return to List | Next Study

A Study in Patients With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02329327
Recruitment Status : Recruiting
First Posted : December 31, 2014
Last Update Posted : May 16, 2018
Sponsor:
Collaborator:
Population Health Research Institute
Information provided by (Responsible Party):
Portola Pharmaceuticals